CVE-2022-3803

Public Exploit
eolinker apinto-dashboard cross site scripting

Description

A vulnerability was found in eolinker apinto-dashboard and classified as problematic. This issue affects some unknown processing of the file /api/discoveries/. The manipulation leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The associated identifier of this vulnerability is VDB-212639.

Categories

3.5
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.07%
Third-Party Advisory im5i.com Third-Party Advisory im5i.com Third-Party Advisory vuldb.com
Affected: eolinker apinto-dashboard
Published at:
Updated at:

References

Link Tags
https://c2.im5i.com/2022/11/01/Xr9Zz.png third party advisory exploit
https://c2.im5i.com/2022/11/01/XroR8.png third party advisory exploit
https://vuldb.com/?id.212639 third party advisory

Frequently Asked Questions

What is the severity of CVE-2022-3803?
CVE-2022-3803 has been scored as a low severity vulnerability.
How to fix CVE-2022-3803?
To fix CVE-2022-3803, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-3803 being actively exploited in the wild?
It is possible that CVE-2022-3803 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-3803?
CVE-2022-3803 affects eolinker apinto-dashboard.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.